Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
HIMSS22 day 3 roundup summary: Glooko acquires DIABNEXT for an unclosed sum, GE Healthcare and AliveCor announces integration, etc.
Source: hitconsultant.net
Page 45 - Real World Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Real World Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Real World Data Today - Breaking & Trending Today
Emyria Ltd begins recruiting for EMD-RX5 Phase 1 clinical safety and bioavailability study
Emyria Ltd (ASX:EMD) has started participant recruitment, screening and consenting for its Phase 1 clinical trial of EMD-RX5, with dosing expected to begin...
Source: proactiveinvestors.com.au
Vital Signs: Digital Health Law Update Winter 2022 | Jones Day
Note From the Editors With 2022 well underway, the rapid pace of statutory, regulatory, policy, and industry activities in digital health continues in force. We bring you Vital Signs, a...
Source: jdsupra.com
Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...
Source: prnewswire.com
Emyria Ltd receives ethics approval for phase one study of CBD medication EMD-RX5
Emyria Ltd (ASX:EMD) has received ethics approval for its phase one clinical trial of EMD-RX5, a proprietary, highly bioavailable oral formulation of...
Source: proactiveinvestors.com.au